Medication Adherence Devices Global Market Report 2025

The medication adherence devices market size has grown strongly in recent years. It will grow from $3.2 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an increasing geriatric population, heightened awareness of the importance of medication adherence, government efforts to minimize hospital readmissions, and the expansion of home healthcare services.

The medication adherence devices market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The projected growth in the forecast period can be attributed to the increasing adoption of connected health devices, rising demand for personalized healthcare, expansion of telehealth services, supportive regulatory frameworks for digital health solutions, and a growing emphasis on reducing healthcare costs. Key trends expected during this period include technological advancements in Internet of Things (IoT) devices, innovations in artificial intelligence for monitoring medication adherence, progress in cloud-based data analytics, ongoing research and development in smart packaging, and the integration of machine learning for predictive adherence solutions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the medication adherence devices market in the coming years. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, often resulting in serious complications such as heart attacks, strokes, and heart failure. The rise in these conditions is largely attributed to more sedentary lifestyles, with many individuals spending prolonged hours in desk-based jobs and engaging in minimal physical activity. Medication adherence devices support the management of cardiovascular diseases by helping patients take their medications consistently and on schedule, thereby reducing the risk of adverse events. For example, in January 2024, the American Heart Association - a U.S.-based nonprofit organization - reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, representing a 4% rise from the previous year’s rate of 224.4 per 100,000. This follows a 4.6% increase the year before. As a result, the growing burden of cardiovascular disease is fueling demand for medication adherence devices.

Leading companies in the medication adherence devices market are prioritizing the development of innovative solutions such as smart pill organizers to facilitate real-time remote monitoring of medication adherence. A smart pill organizer is an electronic device designed to help users manage their medications by offering automated reminders, dispensing pills at scheduled intervals, and syncing with mobile applications for tracking and alerts. For example, in April 2025, Centor Inc., a U.S.-based manufacturer of prescription medication dispensing containers, launched a new smart weekly pill organizer utilizing LTE and cloud technology to enhance medication adherence. This device monitors medication intake in real time and transmits data directly to pharmacies and clinical partners, removing the need for users to download or connect a smartphone app - an especially beneficial feature for elderly or less tech-savvy individuals. Co-developed with RxCap, the organizer is user-friendly and fully integrates with Centor’s remote monitoring services, enabling pharmacies to implement reimbursable adherence programs and deliver timely interventions as needed.

In April 2024, Gerresheimer AG, a Germany-based manufacturer of drug delivery systems and medical devices, entered into a partnership with RxCap to provide connected adherence solutions. The goal of this collaboration is to enable pharmacies to deliver remote therapeutic monitoring services by leveraging smart packaging and cloud-based software, thereby enhancing medication management and improving patient health outcomes. RxCap Inc. is a U.S.-based healthcare technology company specializing in prescription adherence and remote therapeutic monitoring (RPM) solutions.

Major players in the medication adherence devices market are McKesson Corporation, Cardinal Health Inc., Johnson & Johnson Services Inc., Novartis AG, Becton Dickinson and Company, Koninklijke Philips N.V., AptarGroup Inc., Insulet Corporation, Omnicell Inc., Ypsomed Holding AG, MedMinder Systems Inc., Propeller Health Inc., Bigfoot Biomedical Inc., Information Mediary Corp., AARDEX Group SA, Hero Health Inc., CareRight Technologies, Adherium Limited, Popit Oy, SMRxT Inc., Wisepill Technologies Inc., and SeamlessMD.

North America was the largest region in the medication adherence devices market in 2024. The regions covered in medication adherence devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medication adherence devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medication adherence devices are specialized tools or technologies designed to assist patients in consistently following their prescribed medication regimens. These devices provide timely reminders, track medication usage, and, in some cases, automatically dispense doses to help prevent missed or incorrect intake, thereby enhancing treatment effectiveness and improving patient health outcomes.

The primary types of medication adherence devices include hardware-centric and software-centric solutions. Hardware-centric devices are physical tools such as smart pillboxes, automated dispensers, and specialized packaging systems that monitor medication intake and relay data to caregivers. These devices are used for managing various types of medications, including those for cardiovascular conditions, central nervous system disorders, diabetes, oncology, gastrointestinal issues, musculoskeletal problems, and others. They are utilized across different settings, including hospitals, homecare environments, pharmacies, long-term care facilities, and clinics.

The medication adherence devices market research report is one of a series of new reports that provides medication adherence devices market statistics, including medication adherence devices industry global market size, regional shares, competitors with a medication adherence devices market share, detailed medication adherence devices market segments, market trends and opportunities, and any further data you may need to thrive in the medication adherence devices industry. This medication adherence devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medication adherence devices market consists of revenues earned by entities by providing services, such as medication reminder services, remote monitoring services, refill reminders, customizable schedules, data analytics, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The medication adherence devices market also includes sales of smart pill bottles, smart pill dispensers, connected inhalers, remote monitoring systems, and automatic pill crushers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.